Advertisement
Advertisement
PBH
Prestige Consumer Healthcare Inc.
49.60
USDSponsored
-1.02
-2.02%
Nov 19, 15:59 UTC -5
Closed
After-Market
49.65
+0.05
+0.10%
Prestige Consumer Healthcare Inc. (PBH) Earnings
PBH Earnings Reports
Positive Surprise Ratio
PBH beat 33 of 43 last estimates.
77%
Next Report
Date of Next Report
Feb 03, 2027
Estimate for Q3 27 (Revenue/ EPS)
$331.30M
/$1.06
Implied change from Q2 27 (Revenue/ EPS)
-1.49%
/-5.36%
Implied change from Q3 26 (Revenue/ EPS)
+16.89%
/-6.19%
Prestige Consumer Healthcare Inc. earnings per share and revenue
On Nov 05, 2026, PBH reported earnings of 1.12 USD per share (EPS) for Q2 27, beating the estimate of 1.08 USD, resulting in a 4.28% surprise. Revenue reached 336.31 million, compared to an expected 332.42 million, with a 1.17% difference. The market reacted with a -16.82% price change (close before vs. close after earnings).
Looking ahead to Q3 27, -- analysts forecast an EPS of 1.06 USD, with revenue projected to reach 331.30 million USD, implying an decrease of -5.36% EPS, and decrease of -1.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Prestige Consumer Healthcare Inc.'s earnings and revenue for the latest quarter Q2 2027?
For Q2 2027, Prestige Consumer Healthcare Inc. reported EPS of $1.12, beating estimates by 4.28%, and revenue of $336.31M, 1.17% above expectations.
How did the market react to Prestige Consumer Healthcare Inc.'s Q2 2027 earnings?
The stock price moved down -16.82%, changed from $53.28 before the earnings release to $44.32 the day after.
When is Prestige Consumer Healthcare Inc. expected to report next?
The next earning report is scheduled for Feb 03, 2027.
What are the forecasts for Prestige Consumer Healthcare Inc.'s next earnings report?
Based on --
analysts, Prestige Consumer Healthcare Inc. is expected to report EPS of $1.06 and revenue of $331.30M for Q3 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.